Skip to content
GenoLensGenoLens

ATL3

Chr 11q13.1

atlastin GTPase 3

Aliases:
DKFZP564J0863
MANE:
ENST00000398868.8

Annotations refreshed 10 hours ago.

Predicted protein structure

Clinical relevance (Genomics England PanelApp)

Diagnostic Grade (Green)

  • Hereditary neuropathy or pain disorder

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Pain syndromes

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown
  • Hereditary neuropathy

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Familial dysautonomia

    MONOALLELIC, autosomal or pseudoautosomal, NOT imprinted
  • Paroxysmal central nervous system disorders

    MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknown

Disease associations (Open Targets)

  • neuropathy, hereditary sensory, type 1F

    0.72
  • hereditary sensory and autonomic neuropathy type 1

    0.62
  • hereditary disease

    0.19
  • prostate cancer

    0.11
  • Familial prostate cancer

    0.11
  • Charcot-Marie-Tooth disease axonal type 2N

    0.11
  • COVID-19

    0.06
  • Li-Fraumeni syndrome

    0.04
  • Ochoa syndrome

    0.04
  • urofacial syndrome 2

    0.04

Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.

Protein function (UniProt)

Atlastin-3

Atlastin-3 (ATL3) is a membrane-anchored GTPase that mediates the GTP-dependent fusion of endoplasmic reticulum (ER) membranes, maintaining the continuous ER network. It facilitates the formation of three-way junctions where ER tubules intersect (PubMed:18270207, PubMed:19665976, PubMed:24459106, PubMed:27619977, PubMed:37102997). Two atlastin-3 on neighboring ER tubules bind GTP and form loose homodimers through the GB1/RHD3-type G domains and 3HB regions. Upon GTP hydrolysis, the 3HB regions tighten, pulling the membranes together to drive their fusion. After fusion, the homodimer disassembles upon release of inorganic phosphate (Pi). Subsequently, GDP dissociates, resetting the monomers to a conformation ready for a new fusion cycle (By similarity)

Data sources: HGNC (CC BY 4.0), AlphaFold (CC BY 4.0, Jumper et al. Nature 2021), Genomics England PanelApp (CC BY 4.0), ClinGen, Open Targets (CC0), UniProt.

Not for sole clinical decision-making. Always verify against primary sources.